Why Latin America
Outsourcing Clinical Trials
Outsourcing Clinical Trials
Historically, most clinical research has been concentrated in developed nations. This trend is obvious from the geographical distribution of clinical research publications; most of the publications and the research itself come from North America and western Europe.
Nevertheless, the presence of clinical research in Latin America growing steadily in the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.
There are huge financial gains associated with conducting clinical research in Latin America, with up to 50% lower costs when compared to the USA. This is in part because of the materials and actual cost of location for LATAM research centers are less expensive and does not compromise standard-of-care or data validity.
With a population of 600M+, LATAM is one of the less exploited regions for patient recruitment when compared with saturated major centers in the USA and Europe. The lack of clinical trials and the strong bond between patients and physicians, make Latin America fertile ground for patient recruitment and retention.
During the last decade most of Latin American countries have opened agencies and adopted new regulations that adhere to the FDA’s international standards. That is why it is crucial to have a local CRO with the expertise to navigate this changing landscape, and locally-based teams with staff who speak the language, which can save a lot of time during the study start-up phase.
No Walls In Clinical Research
Infrastructure in Latin America
The Cohortias' Difference
Our Infrastructure in Latin America
Cohortias has built a broad network of sites, physicians, investigators and regulatory experts across the Latin American region. This peer-to-peer model allows us to expedite our clinical trial services from the start-up phases all the way to the study termination.
Our experience in the region enables us to understand and comply with local regulations, customs, and language differences and to efficiently work with the culture and the medical practices in each country of the region– ensuring superior trial compliance and expeditious patient enrolment.
It also enables us to provide sound advice to our clients on how to prevent difficulties and delays in the implementation and development of the trials.
Full Service CRO
Revolutionary Pricing Model
Latin America = Market Potential
We Will Help You Every Step Of The Way
Let us guide you through the Clinical Research Landscape of Latin America
Discover our Region
Why Latin America?
Several factors contribute to Latin America being a region of choice to conduct your clinical trials:
Compliance & Retention
Lack of Language Barrier
our team of experts are here for you
Experienced Team of Professionals in Argentina, Brazil, Colombia and Mexico.